A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence

Clinical trial NCT02382276 · COMPLETED

Trial details

NCT number: NCT02382276
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alcohol Dependence

Start date: 2015-07-13
Primary completion: 2017-01-18
Enrollment: 405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.